Key Market Indicator:
F&G: 11
24.520,95 NASDAQ · 46.107,51 DOW · 6.663,65 S&P · 4.067,01 Gold · 64,50 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© PR Newswire
29.08.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Reports 2025 Interim Results and Business Highlights
Article
News Preview
SUZHOU, China, Aug. 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2025 and highlighted recent business progress. Financial Summary For the six months ended June 30, 2025, we recorded total revenue of RMB 319.44 million, an increase of 84.05% compared with the...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Class Action Reminder: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Replimune Group, Inc. Class Action Lawsuit
Article
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ: REPL) securities between November 22, 2024 and July 21, 2025. Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development an...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.08.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
Article
News Preview
LONDON, UK / ACCESS Newswire / August 29, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), is pleased to announce that following the conclusion of the formal tender process for the role of statutory auditor, it intends to re-appoint PKF Littlejohn LLP as external auditor for the financial year ending December 2025 onwards. This will coincide with...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
29.08.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Interim Results for First Half of 2025
Article
News Preview
SHANGHAI, Aug. 29, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 along with a corporate update. "In the first half o...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
29.08.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Interim Results for First Half of 2025
Article
News Preview
SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 along with a corporate update. "In the first half o...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Berger Montague PC Investigating Claims on Behalf of LifeMD, Inc. (NASDAQ: LFMD) Investors After Class Action Filing
Article
News Preview
PHILADELPHIA, Aug. 28, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period")....
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation
Article
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News Release of June 25, 2025, July 8, 2025 and August 5, 2025, it has rescheduled its annual general and special meeting (the "Meeting") from Septem...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US2697961082
Eagle Pharmaceuticals Inc
EGRX
LISTED
NASDAQ
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
Article
News Preview
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subject to customary onboarding procedures. Mr. Jain will be a Class III director with an initial term e...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences
Article
News Preview
WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in September 2025: The Cantor Global Healt...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025
Article
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a fireside chat hosted by J.P. Morgan on Friday, September 5th, at 1:00 p.m. (ET). The live webcast of the fireside chat can be accessed via the Investors section of o...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025
Article
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that Inter...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics to Participate at Upcoming Investor Conferences
Article
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at multiple upcoming investor conferences. ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
28.08.2025
ISIN: CA13509T1057
MTL Cannabis Corp.
MTLC
LISTED
CSE
MTL Cannabis Corp. Reports First Quarter Results with $25.9 Million of Revenue and Announces Transformational Capital Projects
Article
News Preview
Quality Products and Services Drive Continued Positive Operating Income, EBITDA, and Strong Margins PICKERING, ON, Aug. 28, 2025  /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") is pleased to report it has filed the financial statements as at and for the three-month period ending June 30, 2025, and 2024. Complete details may be fo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
AM Best Downgrades Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries; Revises Outlooks to Stable
Article
News Preview
AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “a-” (Excellent) from “a” (Excellent) and the Long and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. Concurrently AM Best has downgraded the Financial Strength Rating (F...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: CA75103L1013
Rakovina Therapeutics Inc.
RKV
LISTED
TSX
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
Article
News Preview
All dollar amounts reflected in Canadian dollars unless otherwise stated All dollar amounts reflected in Canadian dollars unless otherwise stated...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US21217B1008
Contineum Therapeutics, Inc.
CTNM
LISTED
NASDAQ
Contineum Therapeutics to Present at September Investor Conferences
Article
News Preview
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to present at the following investor conferences in September. C...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health to Host Investor Day on September 24, 2025
Article
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be hosting an Investor Day on September 24, 2025, in New York City, NY starting at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. The event will feature presentations by several members of the company's leadership team. Interested parties...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference
Article
News Preview
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on Thursday, Septem...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum to Participate in Upcoming Investor Conferences
Article
News Preview
ST. PAUL, Minn., Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences: 2025 Wells Fargo Healthcare Conference in Boston, Mass....
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Article
News Preview
LOS ANGELES, Aug. 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
Article
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Chief Executive Officer and Co-founder, will participate in two upcoming investor conferences taking place in September: Event: 2025 Wells...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology to Speak at Upcoming Financial Conferences
Article
News Preview
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Article
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES, Aug. 28, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG)....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US74276R1023
Privia Health Group Inc
PRVA
LISTED
NASDAQ
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
Article
News Preview
Privia Health ACOs Delivered $233+M (+32% Y-Y) in Savings in the 2024 MSSP Performance Year; Increases Adjusted EBITDA Guidance for Full-Year 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva gibt Zusammenarbeit mit Global Biotech bekannt, um Innovationen im Bereich klinischer Studien weiter voranzutreiben
Article
News Preview
BARCELONA, Spanien, 28. August 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute eine Zusammenarbeit mit Amgen bekannt, um Innovationen im Bereich klinischer Studien voranzutreiben. Als weltweit führendes Biotechnologieunternehmen wird Amgen die Veeva Clinical Platform einsetzen, um Effizienzsteigerungen im gesamten klinischen Studienproz...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US58510H1032
MEDIROM Healthcare Technologies Inc.
MRM
LISTED
NASDAQ
Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device
Article
News Preview
TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”, “we” or “us”) announces that its “REMONY for Driver” remote health management system, developed by its subsidiary MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has been selected by Japan’s Ministry of Land, Infrastructure, Transport and Tourism (“M...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US5255582018
LeMaitre Vascular Inc
LMAT
LISTED
NASDAQ
LeMaitre to Participate at Upcoming Investor Conferences in September
Article
News Preview
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
Article
News Preview
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen to Present at Upcoming Healthcare Investor Conference
Article
News Preview
Surrozen management will present at the Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Article
News Preview
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that members of the management team will participate in the followi...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US75943R1023
Relay Therapeutics Inc
RLAY
LISTED
NASDAQ
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
Article
News Preview
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US14147L1089
Cardiff Oncology Inc
CRDF
LISTED
NASDAQ
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
Article
News Preview
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in the three upcoming investor conferences in September 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US2825591033
89Bio, Inc.
ETNB
LISTED
NASDAQ
89bio to Participate in Upcoming Investor Conferences
Article
News Preview
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s management will participate in the following investor conferenc...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Securities Fraud Investigation Into LifeMD, Inc. (LFMD) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Article
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON LIFEMD, INC. (...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Article
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
Article
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply
Article
News Preview
Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis thérapeutique Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: SE0007692850
Camurus AB
CAMX
LISTED
STO
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
Article
News Preview
LUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment wi...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Article
News Preview
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Article
News Preview
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US00847G8042
Agenus Inc
AGEN
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Article
News Preview
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /CNW/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate's rece...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD
Article
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Fa...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US8740602052
Takeda Pharmaceutical Company
TAK
LISTED
NYSE
Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC)
Article
News Preview
TORONTO, Aug. 28, 2025 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by Régie de l'assurance maladie (RAMQ) for people in Quebec, under certain criteria, as a treatment for adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with, or...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US62856X2018
TNF Pharmaceuticals, Inc.
TNFA
LISTED
NASDAQ
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
Article
News Preview
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that its board of directors has authorized a reverse stock split of the Company’s common stock at a ratio of 1 post-split share for every 1...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: SE0009807266
Integrum AB (B)
INTEG B
LISTED
STO
Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation
Article
News Preview
MÖLNDAL, Sweden, Aug. 28, 2025 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2025/26 results on September 1, 2025 at 10:00 CET. Integrum's CEO Martin Hillsten will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held i...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Article
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LIFEMD, INC. (LFMD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo to Present in the Wells Fargo Healthcare Conference
Article
News Preview
Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Mas...
Themefolio
Profiler
Peergroup
© Newsfile
28.08.2025
ISIN: CA65347A1021
Nextleaf Solutions Ltd.
OILS
LISTED
CSE
Nextleaf Reports Third Quarter FY25 Results Including Fourth Consecutive Profitable Quarter
Article
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor, is pleased to announce its financial results for the third quarter of fiscal year 2025, ended June 30, 202...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma to participate in upcoming investor conferences in September 2025
Article
News Preview
Press release – No. 12 / 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Investors who lost money on Unicycive Therapeutics, Inc.(UNCY) should contact The Gross Law Firm about pending Class Action - UNCY
Article
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY). Shareholders who purchased shares of UNCY during the class period listed are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
Article
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT). Shareholders who purchased shares of ALT during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
The Gross Law Firm Notifies Centene Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CNC
Article
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Centene Corporation (NYSE: CNC). Shareholders who purchased shares of CNC during the class period listed are encouraged to co...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ANRO
Article
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
Article
News Preview
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company focused on developing novel neuroplastogenic small-molecule therapeutics for the treatment of depression, post-traumatic stress disorder (PTSD), and other neuropsychiatric disorders, today announced the successful completion of 7-day Dose Range Finding (...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US40637H1095
Halozyme Therapeutics Inc
HALO
LISTED
NASDAQ
Halozyme to Participate at Upcoming Investor Conferences
Article
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Tram Bui, VP of Investor Relations and Corporate Communications, are scheduled to participate and host investor meetings at the following investor conferences.  Details...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US04962H2094
Atossa Therapeutics, Inc.
ATOS
LISTED
NASDAQ
Atossa Therapeutics CEO to Discuss Clinical Progress and Upcoming Milestones at 27th Annual H.C. Wainwright Global Investment Conference
Article
News Preview
Dr. Steven Quay, Chairman and Chief Executive Officer to participate in Fireside Chat with Emily Bodnar, HCW Biotech Research Analyst SEATTLE, Aug. 28, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and preve...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: KYG9390W1015
VIVA Biotech Holdings
1873
LISTED
HKSE
Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth
Article
News Preview
Financial Highlights for Interim Results ended 30 June 2025Revenue reached RMB831.9 millionGross profit amounted to RMB339.4 millionGross profit margin was 40.8%, an increase of 6.3 percentage pointNet profit amounted to RMB148.6 million, increased by 3.1% YoYAdjusted non-IFRS net profit reached RMB183.5 million, increased by 9.1% YoY SHANGHAI, A...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
Article
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 27 August 2025 was 356.14p (cum income).                                  ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US81749D1072
Sera Prognostics Inc
SERA
LISTED
NASDAQ
SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
Article
News Preview
SALT LAKE CITY, Aug. 28, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the H.C. Wainwright 27th Annual Global Investment Conference...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Hit With Securities Class Action After Shares Crash 44% On Q2 2025 Earnings Surprise, Problems With Obesity Care and RexMD -- Hagens Berman
Article
News Preview
SAN FRANCISCO, Aug. 28, 2025 /PRNewswire/ -- A securities fraud class action lawsuit styled Johnston v. LifeMD, Inc., et al., No. 1:25-cv-04761 (E.D.N.Y) has been filed and seeks to represent LifeMD (NASDAQ: LFMD) investors who purchased or otherwise acquired LifeMD securities between May 7, 2025 and August 5, 2025....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 19.11.2025, Calendar Week 47, 323rd day of the year, 42 days remaining until EoY.